Keyword: Teva CEO Shlomo Yanai

News

Teva To Buy Cephalon For $6.8 Billion

04.05.2011 - Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...

News

Teva, Procter & Gamble Create OTC Drug Partnership

28.03.2011 - Procter & Gamble and generic drugmaker Teva Pharmaceutical Industries are joining forces to sell over-the-counter medicines as both companies try to expand their reach...